TitleDatePubMed ID
Potent dialkyl substrate-product analogue inhibitors and inactivators of α-methylacyl-coenzyme A racemase from Mycobacterium tuberculosis by rational design.2018 Apr29502025
A study on the AMACR catalysed elimination reaction and its application to inhibitor testing.2016 Jan 1426537174
Selection of aptamers for fluorescent detection of alpha-methylacyl-CoA racemase by single-bead SELEX.2014 Dec 1524994506
α-Methylacyl-coenzyme A racemase (AMACR, p504s) is a marker to distinguish malignant melanomas from dysplastic nevi and melanocytic nevi.2014 Dec25149154
The perils of rational design--unexpected irreversible elimination of fluoride from 3-fluoro-2-methylacyl-CoA esters catalysed by α-methylacyl-CoA racemase (AMACR; P504S).2014 Nov 2525277991
α-Methylacyl-CoA racemase (AMACR) serves as a prognostic biomarker for the early recurrence/metastasis of HCC.2014 Nov25092674
Role of AMACR (α-methylacyl-CoA racemase) and MFE-1 (peroxisomal multifunctional enzyme-1) in bile acid synthesis in mice.2014 Jul 124735479
Trifluoroibuprofen inhibits α-methylacyl coenzyme A racemase (AMACR/P504S), reduces cancer cell proliferation and inhibits in vivo tumor growth in aggressive prostate cancer models.201424712326
Inhibition of human α-methylacyl CoA racemase (AMACR): a target for prostate cancer.2013 Oct23929631
Alpha-methylacyl-coenzyme A racemase expression in neuroendocrine neoplasms of the stomach.2012 Aug22782380